FDA Adverse Event Malfunction Summary report: N

REACTIV8

MDR report key: 19717351 · Received July 11, 2024

Report

Report Number
3013017877-2024-00051
Event Type
Malfunction
Date Received
July 11, 2024
Date of Event
June 12, 2024
Report Date
September 7, 2024
Manufacturer
MAINSTAY MEDICAL LIMITED
Product Code
QLK
UDI-DI
05391527772064
PMA / PMN Number
P190021
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
AS
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

MML REFERENCE #: (B)(4). THE DEVICE WAS NOT RETURNED, AND AN ANALYSIS COULD NOT BE PERFORMED BECAUSE THE LEAD WAS DAMAGED DURING THE EXPLANT, AND PARTS WERE LEFT INSIDE THE PATIENT. THEREFORE, THE ALLEGED OUT-OF-RANGE FAILURE CANNOT BE CONFIRMED. THE DEVICE HISTORY RECORD WAS REVIEWED, AND NO NONCONFORMANCES WERE FOUND TO BE ASSOCIATED WITH THE OUT-OF-RANGE FAILURE.

Additional Manufacturer Narrative · 0

MML REFERENCE #: (B)(4).

Description of Event or Problem · 0

IT WAS REPORTED THAT THE PATIENT UNDERWENT REVISION SURGERY DUE TO THE PROGRESSION OF OUT-OF-RANGE/HIGH IMPEDANCE FAILURE OF THE LEFT LEAD. THERE WAS NO REPORT OF PATIENT HARM OR INJURY. DURING THE EXPLANT PROCEDURE, THE LEFT LEAD BROKE. THE LEAD FRAGMENTS WERE LEFT INSIDE THE PATIENT AT THE SURGEON'S DISCRETION, AND THE PATIENT CONSENTED. A NEW LEAD WAS IMPLANTED SUCCESSFULLY. THERE WAS NO REPORT OF PATIENT HARM OR INJURY.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE PATIENT UNDERWENT REVISION SURGERY DUE TO THE PROGRESSION OF OUT-OF-RANGE/HIGH IMPEDANCE FAILURE OF THE LEFT LEAD. THERE WAS NO REPORT OF PATIENT HARM OR INJURY. DURING THE EXPLANT PROCEDURE, THE LEFT LEAD BROKE. THE LEAD FRAGMENTS WERE LEFT INSIDE THE PATIENT AT THE SURGEON'S DISCRETION, AND THE PATIENT CONSENTED. A NEW LEAD WAS IMPLANTED SUCCESSFULLY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
340696 REACTIV8 REACTIV8 PERCUTANEOUS STIMULATION LEAD QLK MAINSTAY MEDICAL LIMITED 8145 05391527772064

Patients

Seq Age Sex Outcome Treatment
1 65 YR Female